1. Home
  2. USEG vs NSRX Comparison

USEG vs NSRX Comparison

Compare USEG & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Energy Corp. (DE)

USEG

U.S. Energy Corp. (DE)

HOLD

Current Price

$1.04

Market Cap

46.5M

Sector

Energy

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.26

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USEG
NSRX
Founded
1966
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.5M
53.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
USEG
NSRX
Price
$1.04
$2.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$3.50
$19.67
AVG Volume (30 Days)
9.8M
160.9K
Earning Date
03-13-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
55.21
N/A
EPS
N/A
N/A
Revenue
$32,379,000.00
N/A
Revenue This Year
$79.53
N/A
Revenue Next Year
$169.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$2.14
52 Week High
$2.75
$9.99

Technical Indicators

Market Signals
Indicator
USEG
NSRX
Relative Strength Index (RSI) 49.01 27.78
Support Level $0.94 N/A
Resistance Level $1.09 $5.20
Average True Range (ATR) 0.06 0.32
MACD -0.01 -0.08
Stochastic Oscillator 49.29 4.00

Price Performance

Historical Comparison
USEG
NSRX

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: